Document Classification

Section Type: CONCLUSIONS

Text: Mirabegron 50-mg and 100-mg groups demonstrated statistically significant improvements (adjusted mean change from baseline [95 % confidence intervals]) at the final visit in the number of incontinence episodes per 24h (-1. 57 [-1. 79 to -1. 35] and -1. 46 [-1. 68 to -1. 23], respectively, vs placebo -1. 17 [-1. 39 to -0. 95]) and number of micturitions per 24h (-1. 93 [-2. 15 to -1. 72] and -1. 77 [-1. 99 to -1. 56], respectively, vs placebo -1. 34 [-1. 55 to -1. 12] ; p < 0. 05 for all comparisons).